CBIO vs ABSI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 16, 2026

CBIO

44.2
AI Score
VS
ABSI Wins

ABSI

45.7
AI Score

Investment Advisor Scores

CBIO

44score
Recommendation
HOLD

ABSI

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO ABSI Winner
Revenue 1.04M 3.87M ABSI
Net Income -48.12M -74.12M CBIO
Net Margin -4631.4% -1915.8% ABSI
Operating Income -51.09M -79.11M CBIO
ROE -29.5% -36.8% CBIO
ROA -26.3% -31.5% CBIO
Total Assets 182.76M 235.23M ABSI
Cash 171.59M 38.20M CBIO
Current Ratio 9.66 5.63 CBIO
Free Cash Flow -28.56M -55.82M CBIO

Relative Price Performance (Last 90 Days)

CBIO 1M: -10.7% · 3M: -24.9% ABSI 1M: -11.9% · 3M: +20.5%

Current Technical Phase

CBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.8%), weak momentum, RSI 39

RSI (14): 38.6 · Price: $12.72

ABSI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.0 · Price: $9.11

Fundamentals Snapshot

Metric CBIO ABSI
Market Cap — —
Forward P/E -4.9 -13.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.5%
Gross Margin 1.0% -54.0%
Operating Margin -14.3% -107.4%
EPS -7.62 -0.79
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ABSI is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.